Drug Shortage Report for RALIVIA
| Report ID | 158236 |
| Drug Identification Number | 02299208 |
| Brand name | RALIVIA |
| Common or Proper name | RALIVIA |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TRAMADOL HYDROCHLORIDE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | N/A |
| ATC code | N02AX |
| ATC description | OPIOIDS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-04-01 |
| Estimated end date | 2022-06-16 |
| Actual end date | 2022-05-31 |
| Shortage status | Resolved |
| Updated date | 2022-06-02 |
| Company comments | Product has been re-classified as a Control Substance |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-06-02 | English | Compare |
| v6 | 2022-04-21 | French | Compare |
| v5 | 2022-04-21 | English | Compare |
| v4 | 2022-04-14 | French | Compare |
| v3 | 2022-04-14 | English | Compare |
| v2 | 2022-04-07 | French | Compare |
| v1 | 2022-04-07 | English | Compare |
Showing 1 to 7 of 7